ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ERLOTINIB HYDROCHLORIDE BULK AND IN PHARMACEUTICAL DOSAGE FORM

Authors

  • V S Saravanan Dept of Pharmaceutical Analysis, The Erode College of pharmacy, Perundurai Main Road, Vallipurathanpalayam (po), Veppampalayam, ERODE – 638112, Tamilnadu, INDIA.
  • Bojja Mallikarjuna Rao Dept of Pharmaceutical Analysis, The Erode College of pharmacy, Perundurai Main Road, Vallipurathanpalayam (po), Veppampalayam, ERODE – 638112, Tamilnadu, INDIA.

Abstract

A simple, precise, and accurate RP – HPLC method was developed and validated for the  determination of Erlotinib Hydrochloride in bulk and tablet dosage form. Gradient elution at a flow rate of 1.0 mL/min was employed on zorbax XDB C18 (150 X 4.6 I.D., 5µm particle size) at ambient temperature. The mobile phase consisted of Acetonitrile and 0.02M ammonium acetate, adjusted to pH 3.3 with acetic acid. Acetonitrile and water(50:50) was used as a diluents. The UV detection wavelength was 247nm and 20µL of sample was injected. The retention times of Erlotinib Hydrochloride was found to be 4.576 min. The linearity was obtained in the range of 50 – 150 µg/mL. The % RSD for precision and accuracy of the method was found to be less than 1%.  The method was validated as per the ICH guideline. The proposed method was suitable for the analysis of Erlotinib Hydrochloride in tablet formulation for quality control purpose.

Key Words: Erlotinib Hydrochloride, RP – HPLC, UV, %RSD, Method validation

DOI

https://doi.org/10.22270/jddt.v3i1.344

Author Biography

V S Saravanan, Dept of Pharmaceutical Analysis, The Erode College of pharmacy, Perundurai Main Road, Vallipurathanpalayam (po), Veppampalayam, ERODE – 638112, Tamilnadu, INDIA.

Head, Dept of Pharmaceutical Analysis, The Erode College of pharmacy, ERODE – 638112,Tamilnadu, INDIA

Published

2013-01-14
Statistics
Abstract Display: 1007
PDF Downloads: 1256

How to Cite

1.
Saravanan VS, Rao BM. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ERLOTINIB HYDROCHLORIDE BULK AND IN PHARMACEUTICAL DOSAGE FORM. J. Drug Delivery Ther. [Internet]. 2013 Jan. 14 [cited 2026 Jan. 22];3(1). Available from: https://jddtonline.info/index.php/jddt/article/view/344

Issue

Vol. 3 No. 1 (2013): Volume 3, Issue 1, Jan-Feb, 2013

Section

Research

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
Saravanan VS, Rao BM. ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ERLOTINIB HYDROCHLORIDE BULK AND IN PHARMACEUTICAL DOSAGE FORM. J. Drug Delivery Ther. [Internet]. 2013 Jan. 14 [cited 2026 Jan. 22];3(1). Available from: https://jddtonline.info/index.php/jddt/article/view/344
Crossref
Scopus
Google Scholar
Europe PMC